Innate Immunity

Published on 09/02/2015 by admin

Filed under Allergy and Immunology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2036 times

Innate Immunity

Learning Objectives

Key Terms

Acute-phase proteins

Acute-phase response

Adaptive immune response

Complement

Innate immune response

Opsonin

Pyrogen

Toll-like receptor

Introduction

The body is protected from infection by anatomic and physiologic barriers in the skin and in the respiratory, intestinal, and urogenital tracts. If these barriers are breached an innate immune response is generated. In the response, phagocytic cells, antimicrobial proteins and serum enzymes are activated by molecules common to most bacteria. The innate immune response functions to contain an infection until an adaptive response can be mounted against the infective agent. An adaptive response begins 7 to 10 days after infection and consists of antibodies, CD4Th1 inflammatory response or CD8 cytotoxic cells.

Anatomic and Physiologic Barriers

Skin

The skin is an inhospitable environment for bacterial colonization and growth with the exception of staphylococcus epidermidis, bacteria cannot attach to the outer layer of skin or stratum corneum because it is composed of dead keratinocytes, keratin, ceramides, free fatty acid, and cholesterol. Moreover, the stratum corneum is continually shed and renewed by younger keratinocytes pushing up from below. Bacterial colonization is prevented by other factors as well. Perspiration deposits salt on the skin. High salt concentrations create a hypertonic environment that inhibits bacterial growth. Sebaceous glands also produce a waxlike substance called sebum, which contains lactic acid and propionic acid produced by Propionibacterium acnes—a commensal organism found in the sebaceous gland. Sebum reduces the skin pH to between 3.0 and 5.0, and this acidic environment inhibits bacterial growth.

Respiratory Tract

The respiratory tract is protected from infection by ciliated epithelial cells and a mucous layer. Glycosylated mucous proteins cover the entire respiratory tract and trap particulate matter. The coordinated beating of the cilia on respiratory epithelial cilia moves the mucus upward to the glottis, where it is expelled from the airways or swallowed. This mechanism is referred to as the mucociliary escalator. The mucous covering is replaced several times each day, leading to the production of a pint to a quart of mucus per day. Defective escalator function increases the risk of developing respiratory tract infections, sinusitis, and otitis media.

Mucociliary escalator dysfunction can be inherited or can be the result of environmental insults. For example, primary ciliary dyskinesia (PCD) is an inherited syndrome characterized by impaired transport and the abnormal structure of cilia. In this syndrome, lungs and sinuses are prone to repeated infections.

Environmental insults and drugs often affect the function of the mucociliary escalator. For example, halothane, cocaine, and sulfur dioxide are toxic to epithelial cells. Smoking or inhalation of toxic fumes also injures the epithelium causing loss of ciliated cells. Escalator function can be compromised by cold or dry air that often creates a highly viscous mucus that cannot be moved upward by ciliated cells.

Stomach and Intestine

Stomach acid forms a passive barrier to prevent infection of the intestinal tract. With the exception of Helicobacter pylori (the etiologic agent of gastric and duodenal ulcers), most ingested pathogenic bacteria cannot survive in stomach acid. Bile salts found in the intestine also are toxic to bacteria.

Urogenital Tract

The components of the urogenital tract that actively participate in the innate immune response are the urethra and the vaginal mucosa. The urethra is usually sterile because the persistent flushing of urine prevents bacterial attachment to urethral epithelial cells. The acidity of urine also prevents bacterial colonization. In females, the normal flora of the vaginal mucosa prevents colonization by pathogenic microbes. Acids produced by lactobacilli create a slightly acidic mucosal environment that inhibits bacterial growth. The risk of infection increases when the lactobacillus population is reduced, the pH of urine is increased, or both.

Pathogen-Associated Molecular Patterns

Pathogen-associated molecular patterns (PAMPs) are molecular structures or molecules that are shared by most pathogenic bacteria and some viruses. Most components are constituents of microbial cell walls, single-stranded and double-stranded nucleic acids, or unmethylated deoxyribonucleic acid (DNA). Common PAMPs are presented in Table 2-1. In an innate immune response, PAMPs are recognized by several different mechanisms, including the following:

Table 2-1

Common Pathogen-Associated Microbial Patterns in Bacteria, Fungi, and Viruses

Peptidoglycan Gram-positive bacteria
Lipopolysaccharide Gram-negative bacteria
Lipoteichoic acids Gram-positive bacteria
Flagellin Bacteria
Lipoarabinomannan Mycobacteria
Beta 1,3 glycan Fungi
Respiratory syncytial virus (RSV) protein Viruses
Double-stranded ribonucleic acid (RNA) Viruses
Lipopeptides Mycoplasma
Unmethylated CpGDNA Bacteria
Profilin-like molecules Toxoplasma

Unmethylated bacterial deoxyribonucleic acid (DNA) containing cytosine phosphate guanine motifs.

Serum Complement Components and Pathogen-Associated Molecular Patterns

Complement comprises nine serum proteins (Figure 2-1) and produces proinflammatory factors that are chemotactic for phagocytic cells (see Chapter 11). Complement fragments coat bacteria to create opsonins, which are, by definition, molecules that attach to microbes and promote phagocytosis.

Complement can be activated by different mechanisms. In an adaptive response, complement is activated by antigen–antibody complexes (see Chapter 11). Three other mechanisms do not require the presence of antibody and are activated during an innate immune response. Complement can be activated by interaction with select molecules (e.g., zymozan) on microbial surfaces in an alternative complement activation pathway. Lectins (proteins that bind to sugars) also activate the complement cascade in the mannose-binding lectin (MBL) pathway. Some acute phase proteins produced by the liver during inflammation activate the complement cascade (see Acute Phase Response).

Mannose-Binding Lectin Complement Activation Pathway

Collectins are a family of lectins that react with terminal mannose or fructose molecules on microbes and activate complement. The collectin family includes Mannose-binding lectin (MBL), bovine conglutinin, lung surfactants A and D, and bovine collectin 43. Structurally, collectins are multi-meric proteins with a “flower bouquet” or an “X-like” structure (Figure 2-2).

MBL is the most studied of the collectins. MBL circulates in a complex with MBL-associated serine protease 1 and 2 (MASP1 and MASP2). In the presence of calcium, MBL or MASP binds to PAMPs such as N-acetylglucosamine, mannose, and N-acetylmannosamine residues expressed on bacteria, fungi, human immunodeficiency virus (HIV) and influenza virus. Following an initial interaction with target molecules, the serum complement cascade is activated. MBL or MASP activates the C2 and C4 complement component to create a C3 convertase (Figure 2-3).

image
Figure 2-3 The early events of all three pathways of complement activation involve a series of cleavage reactions that culminate in the formation of an enzymatic activity called a C3 convertase, which cleaves complement component C3 into C3b and C3a. The production of the C3 convertase is the point at which the three pathways converge and the main effector functions of complement are generated. C3b binds covalently to the bacterial cell membrane and opsonizes the bacteria, enabling phagocytes to internalize them. C3a is a peptide mediator of local inflammation. C5a and C5b are generated by cleavage of C5b by a C5 convertase formed by C3b bound to the C3 convertase (not shown in this simplified diagram). C5a is also a powerful peptide mediator of inflammation. C5b triggers the late events in which the terminal components of complement assemble into a membrane-attack complex that can damage the membrane of certain pathogens. C4a is generated by the cleavage of C4 during the early events of the classic pathway and not by the action of C3 convertase, hence the ; it is also a peptide mediator of inflammation but its effects are relatively weak. Similarly, C4b, the large cleavage fragment of C4 (not shown), is a weak opsonin. Although the classic complement activation pathway was first discovered as an antibody-triggered pathway, it is now known that C1q can activate this pathway by binding directly to pathogen surfaces, as well as paralleling the mannan-binding (MB)–lectin activation pathway by binding to antibody that is itself bound to the pathogen surface. In the MB-lectin pathway, MASP stands for mannan-binding lectin-associated serine protease. (From Murphy K, Travers P, Walport M: Janeway’s immunobiology, ed 7, New York, 2008, Garland Science, Taylor & Francis Group, LLC.)

Cascade fragment C3b binds to bacterial PAMPs and acts as an opsonin. Other complement fragments such C3a and C5a induce the release of histamine and pharmacologic mediators from mast cells and basophiles. These fragments are called anaphylatoxins. Histamine increases capillary permeability and fluid leaks into tissue. Fluid leaking from capillaries reduces fluid levels in the vessels and precipitates bacteria, rendering them more susceptible to phagocytosis. In addition to their role as anaphylatoxins, C3a and C5a are chemoattractants for phagocytic cells. Complexes of C5b, C6, and C7-C9 create a membrane attack complex that inserts a “tube-like” structure through the bacterial membrane, which results in the death of the bacterium.

Receptor Recognition of Pathogen-Associated Molecular Patterns

Phagocytic cells have a number of receptors that recognize PAMPs on pathogenic microbes. Scavenger, carbohydrate, and Toll-like receptors are important in the recognition of PAMPs. Scavenger receptors bind lipoteichoic acids, endotoxins from gram-negative bacteria, and peptidoglycans from gram-positive bacteria. Carbohydrate receptors recognize mannose or fructose in the terminal sugars of bacterial glycoproteins (Figure 2-4).

Toll-like receptors (TLRs) present on lymphocytes, macrophages, and dendritic cells play a more important role in innate immunity. The 11 different TLRs in mammals usually recognize only one type of PAMP (Table 2-2). For example, TLR-2 binds to the peptidoglycans of Streptococcus and Staphylococcus, whereas TLR-5 only binds the proteins of bacterial flagellae. The ligands for TLR receptors are listed in Table 2-3. Interactions between the PAMP and its receptor activate intracellular signaling and the synthesis of specific small-molecular-weight messengers called cytokines that activate both the innate immune system and the adaptive immune system.

Table 2-2

Ligands for Toll-Like Receptors

Peptidoglycan Gram-positive bacteria TLR-2, TLR-6
Lipopolysaccharide Gram-negative bacteria TLR-4
Lipoteichoic acids Gram-positive bacteria TLR-1, TLR-6
Flagellin Bacteria TLR-5
Lipoarabinomannan Mycobacteria TLR-2, TLR-6
Beta 1,3 glucan Fungi TLR-1, TLR-6
Respiratory syncytial virus (RSV) protein Viruses TLR-4
Double-stranded ribonucleic acid (RNA) Viruses TLR-3
Lipopeptides Mycoplasma TLR-7
Unmethylated CpGDNA Bacteria TLR-9
Profilin-like molecules Toxoplasma TLR-11

Unmethylated bacterial deoxyribonucleic acid (DNA) containing cytosine phosphate guanine motifs.

Receptor Activation and Functional Responses in Innate Immunity

The ligation of PAMPs with Toll-like receptors accelerates the phagocytosis of microbes. During phagocytosis, the cell membrane envelopes bacteria and creates an intracellular vacuole called phagosome. Primary granules fuse with the phagosome to create a phagolysosome. Enzymes in the granule kill the microbes by breaking their cell walls and disrupting membrane function (Figure 2-5). At the same time, the oxygen-dependent killing mechanism produces singlet oxygen, hydrogen peroxide, and hypochlorous acid. These substances, along with nitric oxide, are released into the phagolysosone to kill bacteria.

Interactions between PAMPs and Toll-like receptors on macrophages cause the release of interleukin 6 and interleukin 12 (IL-6 and IL-12) from phagocytic cells. IL-6 plays a role in the proliferation of CD8 cytotoxic T cells. It also upregulates adhesion factors on endothelial cells, which allows the egress of phagocytic cells and lymphocytes from the vasculature. IL-6 may also play a role in autoimmune reactions.

Toll-Like Receptors and Autoimmunity

The ligation of Toll-like receptors and the production of IL-6 result in the inactivation of regulatory cells that control the autoimmune B cells in peripheral blood. The disruption of the regulatory network allows B cells to produce autoantibodies directed at host tissue. For example, systemic lupus erythematosus (SLE) is an autoimmune response that is characterized by autoantibodies directed at DNA. The disease is exacerbated by the recognition of cytosine- and guanosine-containing unmethylated DNA by TLR-9 receptors on leukocytes and the release of IL-6.

Toll-Like Receptors, Endotoxins, and Septic Shock

Lipopolysaccharide endotoxins are biologically important PAMPs. Endotoxins, which are an integral part of the gram-negative cell wall, are released on the death of the bacterium and react with CD14 and TLR-4 receptors on the macrophage surface. Intracellular signaling induces the synthesis and release of proinflammatory cytokines (IL-1, IL-2, IL-6, IL-8, and TNF-α [tumor necrosis factor–alpha]). TNF-α is the central cytokine involved in septic shock syndrome. Manifestations of septic shock include tachycardia, tachypenia, alterations in temperature, and activation of the coagulation cascade. Arterial and venous dilation results in septic shock. As a consequence of hypovolemia, tissue perfusion becomes inadequate, which results in cellular dysfunction. Mortality rate among patients with septic shock ranges from 20% to 80%.

Acute Phase Response

In innate immunity, mammals respond to tissue injury or infection by initiating an acute phase response. The response is characterized by fever, demargination of polymorphonuclear leukocytes (PMNs) and the synthesis of acute-phase proteins by the liver. Acute-phase proteins inhibit bacterial growth or activate the complement cascade. The most common acute-phase proteins are listed in Table 2-3. During the response, white blood cells also produce a wide variety of antimicrobial agents such as cathelicins, defensins, and nitric oxide.

Table 2-3

Acute Phase Proteins Produced during an Inflammatory Response

Acute Phase Proteins Biologic Effects
C-reactive protein (CRP) Activates complement and forms opsonins
Ferritin Binds iron
Haptoglobin Binds hemoglobin and prevents iron uptake
Ceruloplasmin Oxidizes iron
Serum amyloid protein Recruits inflammatory cells

Temperature

Most pathogenic bacteria have a narrow growth range at temperatures between 96°F and 100°F. An elevation in body temperature or fever slows bacterial replication until an adaptive immune response can be generated. Fever is induced by IL-1 and Interferon-gamma (IFN-γ) released by monocytes. The interleukins travel to the hypothalamus and increase the temperature set point. Since these cytokines can regulate temperature, they are termed endogenous pyrogens. Other cytokines (anti-pyretic) such as IL-10 and TNF-α modulate and maintain the temperature response.

Acute Phase Proteins

C-reactive protein (CRP), the most studied acute-phase protein (see Table 2-3), activates the complement cascade. Cleavage of other complement components creates opsonins that bind to microbial PAMPs and promotes phagocytosis. Others acute-phase proteins such as ferritin, haptoglobin, and ceruloplasmin bind or oxidize free iron in serum to prevent microbial growth. Iron is necessary for the synthesis of cytochromes and the production of adenosine triphosphate (ATP).

Antimicrobial Agents Produced by Cells and Tissues

Cathelicidins

Cathelicidins are proteins produced by the PMNs, keratinocytes, and epithelial cells of the respiratory and gastrointestinal tracts. Cathelicidin subsets have different biologic functions. PMN-produced cathelicidins have broad-spectrum microbial toxicity. Other cathelicidins synthesized by epithelial cells bind and neutralize lipopolysaccharide endotoxins. In the skin, keratinocyte cathelicidins are chemotactic for phagocytes and T cells. Animal studies show that cathelicidins are important in host defense against Group A streptococci that cause necrotic skin lesions.

Defensins

Defensins are small (29–35 amino acids) proteins produced by circulating white blood cells and tissue cells. Defensins can be classified into alpha and beta families. Alpha-defensins (α-defensins) are found in neutrophils, macrophages, and Paneth cells in the intestine. Paneth cell defensins are called crypticidins and serve to reduce the number of bacteria in the intestinal lumen. Beta-defensins (β-defensins) are secreted by most leukocytes and epithelial cells.

Defensins have broad-spectrum activity against gram-positive and gram-negative bacteria and kill bacteria in a number of ways. Some defensins create voltage-dependent channels in bacterial membranes that allow the influx of water. Increased osmotic pressure ruptures the bacterial membranes. Other defensins move through bacterial cell walls, bind to target cells, and disrupt normal metabolism.

A specific β-defensin called tracheal antimicrobial peptide (TAP) is found along the entire length of conducting airways. In the lung, the β-1 TAP defensin prevents infection by virulent or opportunistic pathogens. In patients with cystic fibrosis (CF), the TAP is inactivated by high salt concentrations in the respiratory mucosa. This allows development of respiratory tract infections with opportunistic pathogens such as Pseudomonas aeruginosa.

Defensins also prevent the influenza virus from entering target cells. Influenza hemagglutinins are necessary for binding the virus to the target cell. Defensins render the virus noninfectious by cross-linking hemagglutinins, which prevents the normal interaction between the virus and the host cell membrane.

Nitric Oxide

Nitric oxide is a highly reactive molecule produced by macrophages following interactions between Toll-like receptors and PAMPs. In a chemical reaction, nitric oxide synthase oxidizes L-arginine to L-citrulline and nitric oxide (NO). Exposure to NO is cytotoxic to bacteria, fungi, parasites, and tumor cells. Toxicity is related to NO’s ability to inhibit DNA synthesis and mitochondrial respiration. Prolonged NO generation can be detrimental to the body. Chemical reactions between NO and oxygen (O2) forms dinitrogen trioxide in mammalian cell membranes and disrupts normal cellular function.

Pathogen-Associated Microbial Patterns and Vaccines

PAMPs are being considered as additional components of vaccines because they stimulate both the innate and the adaptive immune systems. When added to vaccines, compounds that stimulate and direct the immune response are termed adjuvants (see Chapter 24). Adjuvants work by reducing antigen solubility and releasing small amounts of antigens over an extended period. PAMPs are used adjuvants. A purified PAMP from the tuberculosis bacterium called muramyl dipeptide is used in Freunds complete adjuvant to induce cell-mediated immune response to antigens.

Immunodeficiency and Innate Immunity

Most individuals with an MBL deficiency are healthy, but an increased incidence of otitis media, chronic upper respiratory tract infections, chronic diarrhea, and autoimmunity is seen among them. In infants, MBL may play an important role in the transition from passive immunity from the mother to mature adaptive immune responses.

Summary